SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001619856-23-000124
Filing Date
2023-11-07
Accepted
2023-11-07 16:03:49
Documents
83
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q crbu-20230930.htm   iXBRL 10-Q 1212288
2 EX-31.1 crbu-20230930xexx311.htm EX-31.1 10322
3 EX-31.2 crbu-20230930xexx312.htm EX-31.2 10326
4 EX-32.1 crbu-20230930xexx321.htm EX-32.1 4665
5 EX-32.2 crbu-20230930xexx322.htm EX-32.2 4654
  Complete submission text file 0001619856-23-000124.txt   7203131

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crbu-20230930.xsd EX-101.SCH 52509
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT crbu-20230930_cal.xml EX-101.CAL 71157
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT crbu-20230930_def.xml EX-101.DEF 244676
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crbu-20230930_lab.xml EX-101.LAB 641010
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crbu-20230930_pre.xml EX-101.PRE 447386
77 EXTRACTED XBRL INSTANCE DOCUMENT crbu-20230930_htm.xml XML 1081940
Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710 510-982-6030
Caribou Biosciences, Inc. (Filer) CIK: 0001619856 (see all company filings)

IRS No.: 453728228 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40631 | Film No.: 231383599
SIC: 2836 Biological Products, (No Diagnostic Substances)